← Eichor
Condition: Non Active Secondary Progressive Multiple Sclerosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Active Secondary Progressive Multiple Sclerosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Phase 2/Phase 3 · 1 location(s) · Institute of Psychiatry and Neurology, Warsaw · NCT05961644A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Phase 3 · 20 location(s) · Zenas BioPharma (USA), LLC · NCT07299019Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Phase 2 · 1 location(s) · Tiziana Life Sciences LTD · NCT06890923
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.